EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benefits of Myricetin on Diabetes and Obesity: Advance on the Most Recent Research From 2021 to 2025

Jianbo Xiao

Phytochemicals in Food and Medicine · 2026-03 · 1 (1)

DOI: 10.1002/pfm2.70004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytochemicals in Food and Medicine, online erschienen am 31.03.2026. Verfasst von Jianbo Xiao. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myricetin, a typical favonol in food and medicine, has attracted widespread attention, with many new research papers published every year. This mini‐review highlights the most recent research on myricetin from 2021 to 2025. In the past 5 years, several myricetin or its O ‐glycosides were studied from its natural resources. The benefits of myricetin mostly focus on its effects on diabetes and obesity in vivo. The effect of interaction between myricetin and gut microflora on the management of diabetes and obesity has been one of the growing hot topics. More practice is needed to develop functional foods related to myricetin.

Zitieren

APA

Xiao, J. (2026). Benefits of Myricetin on Diabetes and Obesity: Advance on the Most Recent Research From 2021 to 2025. Phytochemicals in Food and Medicine, 1(1). https://doi.org/10.1002/pfm2.70004

Vancouver

Xiao J. Benefits of Myricetin on Diabetes and Obesity: Advance on the Most Recent Research From 2021 to 2025. Phytochemicals in Food and Medicine. 2026;1(1). doi:10.1002/pfm2.70004

BibTeX
@article{Xiao2026,
  author = {Xiao, Jianbo},
  title = {Benefits of Myricetin on Diabetes and Obesity: Advance on the Most Recent Research From 2021 to 2025},
  journal = {Phytochemicals in Food and Medicine},
  year = {2026},
  volume = {1},
  number = {1},
  doi = {10.1002/pfm2.70004}
}
Kostenlos starten →